SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-07-080776
Filing Date
2007-11-07
Accepted
2007-11-07 17:21:00
Documents
7
Period of Report
2007-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a07-28491_110q.htm 10-Q 946463
2 EX-4.1 a07-28491_1ex4d1.htm EX-4.1 19139
3 EX-10.1 a07-28491_1ex10d1.htm EX-10.1 5318
4 EX-31.1 a07-28491_1ex31d1.htm EX-31.1 12184
5 EX-31.2 a07-28491_1ex31d2.htm EX-31.2 11220
6 EX-32.1 a07-28491_1ex32d1.htm EX-32.1 6037
7 EX-32.2 a07-28491_1ex32d2.htm EX-32.2 6004
  Complete submission text file 0001104659-07-080776.txt   1007894
Mailing Address 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CAMBRIDGE MA 02140
Business Address 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CAMBRIDGE MA 02140 6174972070
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-14732 | Film No.: 071222529
SIC: 2835 In Vitro & In Vivo Diagnostic Substances